Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...

Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

This raises the question: Will employees easily adapt to a shift from remote work to hybrid or full-time office schedules, and do they believe that remote working is more efficient than being in ...

Meanwhile, Leerink Partners analysts doubled down on their confidence in Zepbound's long-term market share. Novo is already licking its wounds from another setbackits experimental two-drug combo ...

Results from a separate trial that were released in 2022 showed patients taking a high dose of Lilly's (LLY.N), opens new tab Zepbound saw more than 20% weight loss. "The results give us greater ...

Zepbound is a medicine you can obtain only by prescription, and it’s typically used to address obesity and other weight-related health concerns. But like many drugs, it has the potential to cause side ...